Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Effect of Fractionated Gamma Knife Radiosurgery on Visual Acuity in Patients With Optic Nerve Tumor Publisher



Kazemi F1, 2 ; Azar M1, 2 ; Kazemi F1, 2 ; Hadisinia T3 ; Teymori J2 ; Geraily G2, 3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Skull Base Research Center, Neurosurgery Department, Iran University of Medical Science, Tehran, Iran
  2. 2. Iran Gamma Knife Center, Tehran, Iran
  3. 3. Medical Physics Department, Tehran University of Medical Sciences, Tehran, Iran

Source: Reports of Practical Oncology and Radiotherapy Published:2021


Abstract

background: stereotactic radiosurgery (srs) method has been considered the first-line treatment option to treat patients involved with pre-optic nerve tumors. however, studies have shown that using fractionated srs, normal tissue sparing and tumor dose can be strongly increased simultaneously. Our main goal was to illustrate the effects of fractionated srs approach in optic nerve tumor treatment and its adjacent sensitive structures. Materials and methods: 19 patients involved in optic nerve tumor with clinical symptoms of vision loss were treated with Gamma Knife radiosurgery in three sessions with 12 hours intervals between them. The prescribed dose was about 6.0 ± 1.2 Gy. patient-related parameters including pre-treatment and after-treatment tumor size, visual acuity and visual field were evaluated using the snell chart and MrI imaging. patients were followed for about 14 months. result: The overall result showed vision improvement for patients with low and moderate visual loss. however, there was no significant improvement in patients with severe visual loss. relative improvement was observed in blind patients, although poorly. There was no evidence of growth, recurrence, or new tumor after treatment in patients. conclusion: Fractionated gamma knife radiosurgery offers a safe and effective alternative for benign lesions adjacent to the optic nerve. © 2021 Greater poland cancer centre. published by Via Medica. All Rights Reserved.